Mankind Pharma Ltd
NSE:MANKIND
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Mankind Pharma Ltd
NSE:MANKIND
|
IN |
|
S
|
STORE Capital Corp
F:S76
|
US |
|
El Puerto de Liverpool SAB de CV
BMV:LIVEPOL1
|
MX |
|
Newtek Business Services Corp
NASDAQ:NEWT
|
US |
|
P
|
Pitney Bowes Inc
XBER:PBW
|
US |
|
Rush Enterprises Inc
NASDAQ:RUSHA
|
US |
|
Fox Corp
LSE:0A0X
|
US |
|
P
|
Prudential PLC
XBER:PRU
|
UK |
|
B
|
BCE Inc
XMUN:BCE1
|
CA |
|
S
|
SLM Corp
XMUN:SM1
|
US |
|
A
|
Alnylam Pharmaceuticals Inc
SWB:DUL
|
US |
|
Capricor Therapeutics Inc
NASDAQ:CAPR
|
US |
|
Murata Manufacturing Co Ltd
TSE:6981
|
JP |
|
RTL Group SA
XETRA:RRTL
|
LU |
|
N
|
National Vision Holdings Inc
SWB:7NV
|
US |
Wall St Price Targets
MANKIND Price Targets Summary
Mankind Pharma Ltd
According to Wall Street analysts, the average 1-year price target for MANKIND is 2 800.86 INR with a low forecast of 2 077.57 INR and a high forecast of 3 381 INR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MANKIND's stock price target?
Price Target
2 800.86
INR
According to Wall Street analysts, the average 1-year price target for MANKIND is 2 800.86 INR with a low forecast of 2 077.57 INR and a high forecast of 3 381 INR.
What is the Revenue forecast for Mankind Pharma Ltd?
Projected CAGR
13%
Over the last 5 years, the compound annual growth rate for Revenue has been 18%. The projected CAGR for the next 3 years is 13%.
What is the Gross Profit forecast for Mankind Pharma Ltd?
Projected CAGR
14%
Over the last 5 years, the compound annual growth rate for Gross Profit has been 18%. The projected CAGR for the next 3 years is 14%.
What is the Operating Income forecast for Mankind Pharma Ltd?
Projected CAGR
17%
Over the last 5 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 3 years is 17%.
What is the Pre-Tax Income forecast for Mankind Pharma Ltd?
Projected CAGR
27%
Over the last 5 years, the compound annual growth rate for Pre-Tax Income has been 7%. The projected CAGR for the next 3 years is 27%.
What is the Net Income forecast for Mankind Pharma Ltd?
Projected CAGR
23%
Over the last 5 years, the compound annual growth rate for Net Income has been 9%. The projected CAGR for the next 3 years is 23%.
